Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Status of adjuvant endocrine therapy for breast cancer.

Schiavon G, Smith IE.

Breast Cancer Res. 2014;16(2):206.

PMID:
25032258
[PubMed - in process]
Free PMC Article
2.

Clinical utility of aromatase inhibitors as adjuvant treatment in postmenopausal early breast cancer.

Loaiza-Bonilla A, Socola F, Glück S.

Clin Med Insights Womens Health. 2013 Jan 22;6:1-11. doi: 10.4137/CMWH.S8692. eCollection 2013. Review.

PMID:
24665209
[PubMed]
Free PMC Article
3.

Tamoxifen for women at high risk of breast cancer.

Nazarali SA, Narod SA.

Breast Cancer (Dove Med Press). 2014 Feb 17;6:29-36. doi: 10.2147/BCTT.S43763. eCollection 2014. Review.

PMID:
24648767
[PubMed]
Free PMC Article
4.

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer.

Kawajiri H, Takashima T, Aomatsu N, Kashiwagi S, Noda S, Onoda N, Ishikawa T, Hirakawa K.

Oncol Lett. 2014 Mar;7(3):663-668. Epub 2014 Jan 14.

PMID:
24527070
[PubMed]
Free PMC Article
5.

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review.

Sperduti I, Vici P, Tinari N, Gamucci T, De Tursi M, Cortese G, Grassadonia A, Iacobelli S, Natoli C.

J Exp Clin Cancer Res. 2013 Nov 11;32:89. doi: 10.1186/1756-9966-32-89. Review.

PMID:
24438135
[PubMed - in process]
Free PMC Article
6.

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update.

Schneider R, Barakat A, Pippen J, Osborne C.

Breast Cancer (Dove Med Press). 2011 Oct 4;3:113-25. doi: 10.2147/BCTT.S22905. Review.

PMID:
24367181
[PubMed]
Free PMC Article
7.

Newer therapies for the treatment of metastatic breast cancer: a clinical update.

Mohan A, Ponnusankar S.

Indian J Pharm Sci. 2013 May;75(3):251-61. doi: 10.4103/0250-474X.117396. Review.

PMID:
24082340
[PubMed]
Free PMC Article
8.

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.

Bianchini G, Pusztai L, Karn T, Iwamoto T, Rody A, Kelly C, Müller V, Schmidt S, Qi Y, Holtrich U, Becker S, Santarpia L, Fasolo A, Del Conte G, Zambetti M, Sotiriou C, Haibe-Kains B, Symmans WF, Gianni L.

Breast Cancer Res. 2013;15(5):R86.

PMID:
24060333
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer.

Hashemi-Meshkini A, Keshavarz K, Gharibnaseri Z, Kheirandish M, Kebriaeezadeh A, Nikfar S, Abdollahi M.

Arch Med Sci. 2013 Jun 20;9(3):472-8. doi: 10.5114/aoms.2013.35347. Epub 2013 May 27.

PMID:
23847669
[PubMed]
Free PMC Article
10.

A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer.

Iwata H, Masuda N, Ohno S, Rai Y, Sato Y, Ohsumi S, Hashigaki S, Nishizawa Y, Hiraoka M, Morimoto T, Sasano H, Saeki T, Noguchi S.

Breast Cancer Res Treat. 2013 Jun;139(2):441-51. doi: 10.1007/s10549-013-2573-3. Epub 2013 May 30.

PMID:
23715630
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.

Lønning PE, Eikesdal HP.

Endocr Relat Cancer. 2013 Jun 24;20(4):R183-201. doi: 10.1530/ERC-13-0099. Print 2013 Aug. Review.

PMID:
23625614
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Long-term efficacy and safety of exemestane in the treatment of breast cancer.

Walker G, Xenophontos M, Chen L, Cheung K.

Patient Prefer Adherence. 2013;7:245-58. doi: 10.2147/PPA.S42223. Epub 2013 Mar 27.

PMID:
23569364
[PubMed]
Free PMC Article
13.

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.

Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C.

Br J Cancer. 2013 Apr 16;108(7):1515-24. doi: 10.1038/bjc.2013.116. Epub 2013 Mar 21.

PMID:
23519057
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.

Goss PE, Ingle JN, Pritchard KI, Ellis MJ, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Johnson DB, Tozer R, D'Souza DP, Chalchal H, Spadafora S, Stearns V, Perez EA, Liedke PE, Lang I, Elliott C, Gelmon KA, Chapman JA, Shepherd LE.

J Clin Oncol. 2013 Apr 10;31(11):1398-404. doi: 10.1200/JCO.2012.44.7805. Epub 2013 Jan 28.

PMID:
23358971
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.

Sweeney EE, McDaniel RE, Maximov PY, Fan P, Jordan VC.

Horm Mol Biol Clin Investig. 2012 Feb;9(2):143-163.

PMID:
23308083
[PubMed]
Free PMC Article
16.

Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis.

van de Water W, Seynaeve C, Bastiaannet E, Markopoulos C, Jones SE, Rea D, Hasenburg A, Putter H, Hille ET, Paridaens R, de Craen AJ, Westendorp RG, van de Velde CJ, Liefers GJ.

Oncologist. 2013;18(1):8-13. doi: 10.1634/theoncologist.2012-0315. Epub 2012 Dec 20.

PMID:
23263290
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).

Kubo M, Kanaya N, Petrossian K, Ye J, Warden C, Liu Z, Nishimura R, Osako T, Okido M, Shimada K, Takahashi M, Chu P, Yuan YC, Chen S.

Breast Cancer Res Treat. 2013 Jan;137(1):93-107. doi: 10.1007/s10549-012-2332-x. Epub 2012 Nov 18.

PMID:
23160924
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.

Hadji P, Coleman R, Gnant M, Green J.

Ann Oncol. 2012 Nov;23(11):2782-90. doi: 10.1093/annonc/mds169. Epub 2012 Jun 22. Review.

PMID:
22730099
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Exemestane in the prevention setting.

Litton JK, Bevers TB, Arun BK.

Ther Adv Med Oncol. 2012 May;4(3):107-12. doi: 10.1177/1758834012438214.

PMID:
22590484
[PubMed]
Free PMC Article
20.

Exemestane for breast cancer prevention: a critical shift?

Decensi A, Dunn BK, Puntoni M, Gennari A, Ford LG.

Cancer Discov. 2012 Jan;2(1):25-40. doi: 10.1158/2159-8290.CD-11-0248. Review.

PMID:
22585166
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk